Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Generate Biomedicines

Biotech & Life Sciences · Somerville, United States · Founded 2020 · IPO 2026 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$2.04B
Market cap · Feb/2026
Revenue
$32M
Latest reported FY

Investors

14 investors on Generate Biomedicines's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 14 investors entered at this stage
ARCH Venture Partners
MAPS Capital Management
NVentures
Altitude Life Science Ventures
Alaska Permanent Fund
Fidelity Investments
Amgen
T. Rowe Price
Pictet
March Capital Partners
Abu Dhabi Investment Authority
Samsung Life Science Fund
Flagship Pioneering
Morningside

Global footprint

Where Generate Biomedicines has talent and traffic

AI talent share
8.0% of workforce is AI talent
(26 of 325 staff)
Core AI185.54%
Other AI82.46%
Non-AI workforce29992%
Web traffic by country
32K monthly visits
across markets
🇺🇸 United States59.4%
🇬🇧 United Kingdom22.2%
🇩🇪 Germany5.3%
🇮🇳 India2.5%
🇨🇦 Canada2.5%
Top 5 markets shown

Patent intelligence

$233k patent portfolio · 6 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$233k
0.01% of market cap · 32.6× smaller than top peer Sophia Genetics ($8M)
6 active patent families
Where Generate Biomedicines innovates BioinformaticsAntigen Binding FragmentViral infectionAntigen bindingVirology
Below peer median on Legal, Strategic, Market, Economic, Technology

Quality vs same-sector peers

Generate Biomedicines on the five Patsnap quality dimensions

Generate Biomedicines in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Generate Biomedicines concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Generate Biomedicines and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Generate Biomedicines on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo